Volume 12, Issue 2 (6-2024)                   JoMMID 2024, 12(2): 121-130 | Back to browse issues page

Ethics code: IEC No.1411

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Yadav R, Mehta S, Bala R, kumar Singh V A, Khullar M, Singh P. Emergence of Multidrug-Resistant and Extensively Drug-Resistant Non-Fermenting Gram-Negative Bacilli in a Tertiary Hospital in India. JoMMID 2024; 12 (2) :121-130
URL: http://jommid.pasteur.ac.ir/article-1-636-en.html
Emergence of Multidrug-Resistant and Extensively Drug-Resistant Non-Fermenting Gram-Negative Bacilli in a Tertiary Hospital in India
Rinku Yadav , Sonia Mehta , Rosy Bala , Varsha Ashok Kumar Singh , Muskan Khullar , Parminder Singh
Department of Microbiology, B.R. Ambedkar State Institute of Medical Sciences, Mohali, Punjab, India. Pin Code: 160055
Abstract:   (94 Views)
Introduction: Non-fermenting Gram-negative bacilli (NFGNB), particularly the Acinetobacter baumannii complex (ABC) and Pseudomonas aeruginosa, are common causes of infections in both hospitalized patients and outpatients, posing significant clinical and therapeutic challenges. The primary objective of this study was to conduct a comprehensive analysis of NFGNB, specifically ABC and P. aeruginosa, isolated from pus specimens obtained from both hospitalized patients and outpatients. Methods: This study investigated the antibiotic resistance patterns of NFGNB, focusing on ABC and P. aeruginosa, isolated from pus samples collected from both hospitalized patients and outpatients. The isolates were tested for multidrug resistance (MDR) and extensive drug resistance (XDR) using standardized microbiological protocols. The data were analyzed using descriptive statistics to summarize the findings. Results: Out of 1234 pus samples received, 117 (9.5%) NFGNB were isolated, accounting for 30% of the total Gram-negative bacilli (GNB) isolates. The majority of NFGNB (82.9%, n = 97/117) were isolated from inpatients, with surgical site infections being the most common clinical condition (33.3%, n = 39/117). Among the NFGNB isolates, P. aeruginosa was the predominant species (76.9%, n = 90/117), followed by A. baumannii (22.2%, n = 26/117). Antimicrobial susceptibility testing revealed that 37.7% (n = 34/90) of P. aeruginosa isolates were MDR and 13% (n = 12/90) were XDR, while 65% (n = 17/26) of A. baumannii isolates were MDR and 26.9% (n = 7/26) were XDR. Conclusion: This study highlights the emergence of NFGNB as significant nosocomial pathogens, exhibiting a high degree of resistance to commonly used antibiotics. The findings underscore the urgent need to enhance and strictly implement effective antibiotic stewardship policies, including the development of new antibiotic regimens and antimicrobial resistance surveillance programs, to combat the growing resistance of nosocomial pathogens and ultimately improve patient outcomes.
Keywords: Acinetobacter baumannii, Multidrug-resistant (MDR), Extensive drug resistant (XDR), Non-fermenting Gram-negative bacteria (NFGNB), Pseudomonas aeruginosa
Full-Text [PDF 1077 kb]   (30 Downloads)    
Type of Study: Original article | Subject: Anti-microbial agents, resistance and treatment protocols
Received: 2023/12/17 | Accepted: 2024/09/20 | Published: 2024/09/18
References
1. Malini A, Deepa E, Gokul B, Prasad S. Nonfermenting Gram-negative bacilli infections in a tertiary care hospital in kolar, karnataka. J Lab Physicians. 2009; 1 (2): 62-6. [DOI:10.4103/0974-2727.59701]
2. Munita JM, Arias CA. Mechanisms of Antibiotic Resistance. Microbiol Spectr. 2016; 4 (2): 10 [DOI:10.1128/microbiolspec.VMBF-0016-2015]
3. van Duin D, Paterson DL. Multidrug-Resistant Bacteria in the Community: Trends and Lessons Learned. Infect Dis Clin North Am. 2016; 30 (2): 377-90. [DOI:10.1016/j.idc.2016.02.004]
4. Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health. 2015; 109 (7): 309-18. [DOI:10.1179/2047773215Y.0000000030]
5. Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. P T. 2015; 40 (4): 277-83.
6. Bassetti M, Peghin M, Vena A, Giacobbe DR. Treatment of Infections Due to MDR Gram-Negative Bacteria. Front Med (Lausanne). 2019; 6: 74. [DOI:10.3389/fmed.2019.00074]
7. Buzilă ER, Năstase EV, Luncă C, Bădescu A, Miftode E, Iancu LS. Antibiotic resistance of non-fermenting Gram-negative bacilli isolated at a large Infectious Diseases Hospital in North-Eastern Romania, during an 11-year period. Germs. 2021; 11 (3): 354-62. [DOI:10.18683/germs.2021.1272]
8. Nazir A. Multidrug-resistant Acinetobacter septicemia in neonates: A study from a teaching hospital of Northern India. J Lab Physicians. 2019; 11 (1): 23-8. [DOI:10.4103/JLP.JLP_129_18]
9. Balram Bhargava. Standard Operating Procedures Bacteriology, Antimicrobial Resistance Surveillance and Research Network, Division of Publication and Information, ICMR, India. 2nd Edition, 2019.
10. Haque M, Sartelli M, McKimm J, Abu Bakar M. Health care-associated infections - an overview. Infect Drug Resist. 2018; 11: 2321-33. [DOI:10.2147/IDR.S177247]
11. Kamalraj M, Sivashankari S, Thamari S, Apurba SS. Study on non-fermenting gram negative bacilli from various clinical samples in a tertiary care hospital. Int J Biol Med Res. 2015; 6 (4): 5230-5.
12. Mirzaei B, Bazgir ZN, Goli HR, Iranpour F, Mohammadi F, Babaei R. Prevalence of multi-drug resistant (MDR) and extensively drug-resistant (XDR) phenotypes of Pseudomonas aeruginosa and Acinetobacter baumannii isolated in clinical samples from Northeast of Iran. BMC Res Notes. 2020; 13 (1): 380. [DOI:10.1186/s13104-020-05224-w]
13. Rahbar M, Mehragan H, Akbari N. Prevalence of drug resistance in non-fermenter gram-negative bacilli. Iran J Pathol. 2010; 5 (2): 90-6.
14. Bhargava D, Kar S, Saha M. Prevalence of non-fermentative gram negative bacilli infection in tertiary care hospital in Birgunj, Nepal. Int J Curr Microbiol Appl Sci. 2015; 4 (7): 301-7.
15. Sharma D, Vyas N, Sinha P, Mathur A. Non fermentative gram-negative bacilli as nosocomial pathogens: identification and antibiotic sensitivity in clinical samples of indoor patients. Nepal J Med Sci. 2014; 3 (2): 101-5. [DOI:10.3126/njms.v3i2.13452]
16. Mohan N, Gnanasekar D, Tk S, Ignatious A. Prevalence and Risk Factors of Surgical Site Infections in a Teaching Medical College in the Trichy District of India. Cureus. 2023; 15 (5): e39465. [DOI:10.7759/cureus.39465]
17. Al-Zaidi JR. Antibiotic susceptibility patterns of Pseudomonas aeruginosa isolated from clinical and hospital environmental samples in Nasiriyah, Iraq. Afr J Microbiol Res. 2016; 10 (23): 22. [DOI:10.5897/AJMR2016.8042]
18. Chaudhary NK, Dhakal S. Current Challenges in Antibiotic resistance: Non-fermenting Gram-negative bacilli with Special References to Pseudomonas species and Acinetobacter species. JMSCR. 2021; 9(3):42-48.
19. Gupta A, Malhotra S, Sidhu SK, Devi P, Malhotra SK. Bacteriological profile and antimicrobial susceptibility pattern of pyoderma in a tertiary care hospital. Asian Pac. J Health Sci. 2017; 4 (4): 39 42. [DOI:10.21276/apjhs.2017.4.4.11]
20. Somily A, Balkhy HH, Enani MA, Althawadi SI, Alawi M, Al Johani SM, et al. Antimicrobial resistance trends of non-fermenter Gram negative bacteria in Saudi Arabia: A six-year national study. J Infect Public Health. 2021; 14 (9): 1144-50. [DOI:10.1016/j.jiph.2021.07.007]
21. Raytekar NA, Choudhari MR, Das S. Antibiotic profiling of Pseudomonas aeruginosa isolates from pus sample of rural tertiary care hospital of Western Maharashtra, Loni, India. Int J Res Med Sci. 2017; 5 (7): 3076-81. [DOI:10.18203/2320-6012.ijrms20172990]
22. Grewal US, Bakshi R, Walia G, Shah PR. Antibiotic susceptibility profiles of non-fermenting gram-negative Bacilli at a Tertiary Care Hospital in Patiala, India. Niger Postgrad Med J. 2017; 24 (2): 121-5. [DOI:10.4103/npmj.npmj_76_17]
23. Soni M, Kapoor G, Perumal N, Chaurasia D. Emergence of Multidrug-Resistant Non-Fermenting Gram-Negative Bacilli in a Tertiary Care Teaching Hospital of Central India: Is Colistin Resistance Still a Distant Threat? Cureus. 2023; 15 (5): e39243. [DOI:10.7759/cureus.39243]
24. Rao DR, Basu R, Biswas DR. Aerobic Bacterial Profile and Antimicrobial Susceptibility Pattern of Pus Isolates in a South Indian Tertiary Care Hospital. IOSR-JDMS. 2014; 13 (3): 59-62. [DOI:10.9790/0853-131115962]
25. Kishor N, Chakraverti K t, Singh NS Prevalence and Antibiotic Susceptibility of Gram Negative Nonfermenting bacilli Isolates Obtained from Different Clinical samples in a tertiary care hospital. Int J Health Res. 2021;4(2): 110-3.
26. Maniyan G, Vedachalam D, Chinnusamy N. Characterization and antimicrobial susceptibility pattern of non-fermenting gram negative bacilli from various clinical samples in a tertiary care hospital. Indian J Microbiol Res. 2016; 3 (4): 387-91.
27. Sambyal S, Sharma P Shrivastava D. Anti-biofilm Activity of Selected Plant Essential Oils against Pseudomonas aeruginosa and Staphylococcus aureus. IJCMAS. 2017; 6 (3): 444-50. [DOI:10.20546/ijcmas.2017.603.051]
28. Kaur A, Gupta V, Chhina D. Prevalence of metalo-β-lactamase-producing (MBL) Acinetobacter species in a tertiary care hospital. Iran J Microbiol. 2014; 6 (1): 22-5.
29. Kakati B, Nupur K, Sonika A, Garima M. Multidrug resistant Acinetobacter baumannii causing Ventilator associated respiratory infections at a tertiary care center of India. IP Int J Med Microbiol Trop Dis. 2022; 8 (1): 15-8. [DOI:10.18231/j.ijmmtd.2022.004]
30. Bartal C, Rolston KVI, Nesher L. Carbapenem-resistant Acinetobacter baumannii: Colonization, Infection and Current Treatment Options. Infect Dis Ther. 2022; 11 (2): 683-94. [DOI:10.1007/s40121-022-00597-w]
31. Ndzabandzaba S, Mothibi L, von Knorring N. Non-fermenter Gram-negative bacilli at a tertiary hospital, South Africa. S Afr J Infect Dis. 2023; 38 (1): 538. [DOI:10.4102/sajid.v38i1.538]
32. Morales-Durán N, León-Buitimea A, Morones-Ramírez JR. Unraveling resistance mechanisms in combination therapy: A comprehensive review of recent advances and future directions. Heliyon. 2024; 10 (6): e27984. [DOI:10.1016/j.heliyon.2024.e27984]
33. Mączyńska B, Jama-Kmiecik A, Sarowska J, Woronowicz K, Choroszy-Król I, Piątek D, et al. Changes in Antibiotic Resistance of Acinetobacter baumannii and Pseudomonas aeruginosa Clinical Isolates in a Multi-Profile Hospital in Years 2017-2022 in Wroclaw, Poland. J Clin Med. 2023; 12 (15): 5020. [DOI:10.3390/jcm12155020]
34. Cang HQ, Quan XH, Chu XH, Liang Y, Yang X, Li J. Carbapenems versus β-lactam and β-lactamase inhibitors for treatment of nosocomial pneumonia: A systematic review and meta-analysis. Heliyon. 2023; 9 (10): e20108. [DOI:10.1016/j.heliyon.2023.e20108]
35. Mauri C, Maraolo AE, Di Bella S, Luzzaro F, Principe L. The Revival of Aztreonam in Combination with Avibactam against Metallo-β-Lactamase-Producing Gram-Negatives: A Systematic Review of In Vitro Studies and Clinical Cases. Antibiotics (Basel). 2021; 10 (8): 1012. [DOI:10.3390/antibiotics10081012]
36. Rossolini GM, Mantengoli E. Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa. Clin Microbiol Infect. 2005; 11 (4): 17-32. [DOI:10.1111/j.1469-0691.2005.01161.x]
37. Batarseh A, Al-Sarhan A, Maayteh M, Al-Khatirei S, Alarmouti M. Antibiogram of multidrug resistant Acinetobacter baumannii isolated from clinical specimens at King Hussein Medical Centre, Jordan: a retrospective analysis. East Mediterr Health J. 2016: 21 (11): 828-34. [DOI:10.26719/2015.21.11.828]
38. Yeruva S, Kabra V. Identification and Antimicrobial Susceptibility testing of Non Fermenting Gram Negative Bacteria by Vitek 2 in a Teaching Hospital in Mahbubnagar. Int. J Curr Microbiol App Sci. 2018; 7 (10): 234-40. [DOI:10.20546/ijcmas.2018.710.024]
39. Ko KS, Suh JY, Kwon KT, Jung SI, Park KH, Kang CI, et al. High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea. J Antimicrob Chemother. 2007; 60 (5): 1163-7. [DOI:10.1093/jac/dkm305]
40. Sodhi K, Mittal V, Arya M, Kumar M, Phillips A, Kajla B. Pattern of colistin resistance in Klebsiella isolates in an Intensive Care Unit of a tertiary care hospital in India. J Infect Public Health. 2020; 13 (7): 1018-21. [DOI:10.1016/j.jiph.2019.10.013]
41. Premanadham N, Madhurima, Kumar MMC, Avinash G, Krishna AS, Kumar R. Prevalence of Multi Drug Resistant Non- fermenter Acientobacter baumanni and Pseudomonas aeruginosa in Narayana Medical College and Hospital, Nellore, AP, India. Int J Curr Microbiol App Sci. 2018; 7 (10): 2529-39 [DOI:10.20546/ijcmas.2018.710.294]
42. Jaggi N, Sissodia P, Sharma L. Acinetobacter baumannii isolates in a tertiary care hospital: Antimicrobial resistance and clinical significance. J Microbil Infect Dis. 2012; 2 (2): 57-63. [DOI:10.5799/ahinjs.02.2012.02.0043]
43. Gill MM, Usman J, Kaleem F, Hassan A, Khalid A, Anjum R, Fahim Q. Frequency and antibiogram of multi-drug resistant Pseudomonas aeruginosa. J Coll Physicians Surg Pak. 2011; 21 (9): 531-4.
44. Yadav SK, Bhujel R, Mishra SK, Sharma S, Sherchand JB. Emergence of multidrug-resistant non-fermentative gram negative bacterial infection in hospitalized patients in a tertiary care center of Nepal. BMC Res Notes. 2020; 13: 319. [DOI:10.1186/s13104-020-05163-6]
Add your comments about this article : Your username or Email:
CAPTCHA
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.